Chemring Group plc (LON:CHG) was upgraded by Liberum Capital to a “buy” rating in a research report issued on Thursday. The firm presently has a GBX 175 ($2.17) target price on the stock. Liberum Capital’s price objective indicates a potential upside of 19.66% from the stock’s previous close.
Several other equities research analysts also recently issued reports on CHG. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 145 ($1.79) price objective on shares of Chemring Group plc in a report on Wednesday, June 15th. Canaccord Genuity restated a “hold” rating and set a GBX 135 ($1.67) price target on shares of Chemring Group plc in a report on Thursday, September 1st. Panmure Gordon restated a “hold” rating and set a GBX 107 ($1.32) price target on shares of Chemring Group plc in a report on Thursday, July 14th. Finally, Barclays PLC restated an “underweight” rating on shares of Chemring Group plc in a report on Thursday, August 18th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 164.33 ($2.03).
Chemring Group plc (LON:CHG) opened at 145.25 on Thursday. Chemring Group plc has a 52 week low of GBX 90.25 and a 52 week high of GBX 200.59. The stock has a 50 day moving average price of GBX 143.53 and a 200 day moving average price of GBX 136.33.
In other Chemring Group plc news, insider Flowers ,Michael acquired 15,000 shares of the stock in a transaction dated Thursday, August 11th. The stock was acquired at an average cost of GBX 133 ($1.65) per share, with a total value of £19,950 ($24,690.59).
About Chemring Group plc
Receive News & Ratings for Chemring Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemring Group plc and related companies with MarketBeat.com's FREE daily email newsletter.